Autophagy in aging and in neurodegenerative disorders

被引:0
作者
Yogendra S. Rajawat
Ioannis Bossis
机构
[1] University of Maryland,Department of Veterinary Medicine
来源
Hormones | 2008年 / 7卷
关键词
Aging; Alzheimer’s disease; Autophagy; Lifespan; Lipofuscin; Lysosomes; Mitochondria; Neurodegenerative diseases; Neuronal aging; ROS;
D O I
暂无
中图分类号
学科分类号
摘要
Autophagy (ATG) is the process of bulk degradation and recycling of long-lived proteins, macromolecular aggregates, and damaged intracellular organelles. Cellular homeostasis requires continuous removal of worn-out components and replacement with newly synthesized ones. Studies in yeast and other mammalian systems have increased our knowledge of the molecular mechanism of autophagy and the role of autophagy in various pathological conditions. Discovery of the genes involved in the process of autophagy has provided insight into the involvement of various molecular pathways. Growing evidence has indicated that diminished autophagic activity may play a pivotal role in the aging process. Cellular aging is characterized by a progressive accumulation of nonfunctional cellular components owing to oxidative damage and a decline in turnover rate and housekeeping mechanisms. Lysosomes are key organelles in the aging process due to their involvement in both macroautophagy and other housekeeping mechanisms. Autophagosomes themselves have limited degrading capacity and rely on fusion with lysosomes. Accumulation of defective mitochondria also appears to be critical in the progression of aging. Inefficient removal of nonfunctional mitochondria by lysosomes constitutes a major issue in the aging process. Autophagy has been associated with a growing number of pathological conditions, including cancer, myopathies, and neurodegenerative disorders. In this review, we discuss the cellular and molecular mechanisms involved in autophagy, the mechanisms of aging, and the possible role of autophagy in this process. Understanding the mechanisms by which autophagy impacts aging may provide useful molecular targets for pharmaceuticals designed to delay aging or correct conditions of premature aging.
引用
收藏
页码:46 / 61
页数:15
相关论文
共 382 条
[1]  
Goldberg AL(2003)Protein degradation and protection against misfolded or damaged proteins Nature 426 895-899
[2]  
Ciechanover A(2005)Proteolysis: from the lysosome to ubiquitin and the proteasome Nat Rev Mol Cell Biol 6 79-87
[3]  
Myung J(2001)The ubiquitin-pro-teasome pathway and proteasome inhibitors Med Res Rev 21 245-273
[4]  
Kim KB(1997)Structure and physiological function of calpains Biochem J 328 721-732
[5]  
Crews CM(2004)Autophagy: many paths to the same end Mol Cell Biochem 263 55-72
[6]  
Sorimachi H(2003)Changes in rat liver mitochondria with aging. Lon protease-like reactivity and N (epsilon)-carboxymethyllysine accumulation in the matrix Eur J Biochem 270 2295-2302
[7]  
Ishiura S(2002)Membrane protein degradation by AAA proteases in mitochondria Biochim Biophys Acta 1592 89-96
[8]  
Suzuki K(2004)Development by self-digestion: molecular mechanisms and biological functions of autophagy Dev Cell 6 463-477
[9]  
Cuervo AM(1994)Regulation of intracellular protein degradation with special reference to lysosomes: role in cell physiology and pathology Int Rev Exp Patho 35 39-147
[10]  
Bakala H(2000)LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing EMBO J 19 5720-5728